市場調查報告書

幹細胞市場 - 類型·應用·技術·各地區:市場規模·佔有率·展望·機會分析 (2020-2027年)

Stem Cells Market, By Type, By Application, By Technology, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968767
出版日期 內容資訊 英文 187 Pages
商品交期: 2-3個工作天內
價格
幹細胞市場 - 類型·應用·技術·各地區:市場規模·佔有率·展望·機會分析 (2020-2027年) Stem Cells Market, By Type, By Application, By Technology, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年10月07日內容資訊: 英文 187 Pages
簡介

幹細胞分為兩大類:多能幹細胞和多能幹細胞。多能幹細胞是衍生自胚胎或胎兒組織的複制性細胞。多能幹細胞促進包括葉肉,外胚層和子宮內膜在內的三個主要胚胎中細胞和組織的發育。在預測期內,阻礙幹細胞市場增長的主要因素是成本高和缺乏熟練的專業人員。

本報告提供全球幹細胞市場相關調查,提供市場概要,影響市場的因素分析,各市場區隔·各地區的市場分析,並提供主要企業簡介等資訊。

目錄

第1章 調查目的·前提條件

  • 調查目的
  • 假設
  • 簡稱

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各類型
    • 市場明細:各應用領域
    • 市場明細:各技術
  • Coherent Opportunity Map (COM)

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的發展
  • 法規方案
  • PEST分析
  • COVID-19影響分析

第4章 全球幹細胞市場:各類型

  • 簡介
  • 成體幹細胞
  • 人類胚胎幹細胞
  • 誘導性多功能幹細胞
  • 天然蓮座叢細胞
  • 極小胚胎樣幹細胞 (VSEL)
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長率
    • 市場區隔趨勢

第5章 全球幹細胞市場:各應用領域

  • 簡介
  • 再生醫療
  • 藥物研發&開發
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長率
    • 市場區隔趨勢

第6章 全球幹細胞市場:各技術

  • 簡介
  • 細胞獲得
  • 細胞生產
  • 凍結保存
  • 增生&二次培養
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長率
    • 市場區隔趨勢

第7章 全球幹細胞市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他南美國家
  • 中東
    • GCC各國
    • 以色列
    • 其他中東
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情形

  • 企業簡介
    • Advanced Cell Technology, Inc.
    • Angel Biotechnology Holdings PLC
    • Bioheart Inc.
    • Lineage Cell Therapeutics
    • BrainStorm Cell Therapeutics, Inc.
    • California Stem Cell Inc.
    • Celgene Corporation
    • Takara Bio Europe AB
    • Cellular Engineering Technologies
    • Cytori Therapeutics Inc.
    • Osiris Therapeutics
    • STEMCELL Technologies Inc

第9章 章節

目錄

Title:
Stem Cells Market, By Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Natural Rosette Cells, Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, Drug Discovery and Development), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Stem cells are divided into two major classes; pluripotent and multipotent. Pluripotent stem cells are replicating cells, which are derived from the embryo or fetal tissues. The pluripotent stem cells facilitate the development of cells and tissues in three primary germ layers such as mesoderm, ectoderm, and endoderm.

Restraints of the Global Stem Cells Market

Major factors hampering the growth of the stem cells market during the forecast period constitutes of high costs, and lack of skilled professionals.

Key features of the study:

  • This report provides in-depth analysis of the global stem cells market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global stem cells market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics., BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., Celgene Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Stem Cells Market, By Type:
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • Global Stem Cells Market, By Application:
    • Regenerative Medicine
    • Drug Discovery and Development
  • Global Stem Cells Market, By Technology:
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • Global Stem Cells Market, By Geography:
    • North America
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • Advanced Cell Technology, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Angel Biotechnology Holdings PLC
    • Bioheart Inc.
    • Lineage Cell Therapeutics
    • BrainStorm Cell Therapeutics, Inc.
    • California Stem Cell Inc.
    • Celgene Corporation
    • Takara Bio Europe AB
    • Cellular Engineering Technologies
    • Cytori Therapeutics Inc.
    • Osiris Therapeutics
    • STEMCELL Technologies Inc

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Application
  • Market Snippet, By Technology
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis

4. Global Stem Cells Market, By Type, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Adult Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Human Embryonic Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Induced Pluripotent Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Natural Rosette Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Very Small Embryonic Like Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

5. Global Stem Cells Market, By Application, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Stem Cells Market, By Technology, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Cell Acquisition
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Cell Production
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Cryopreservation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Expansion and Sub-Culture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Stem Cells Market, By Regions, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
  • Advanced Cell Technology, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Angel Biotechnology Holdings PLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bioheart Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lineage Cell Therapeutics
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BrainStorm Cell Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • California Stem Cell Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Celgene Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takara Bio Europe AB
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cellular Engineering Technologies
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cytori Therapeutics Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Osiris Therapeutics
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • STEMCELL Technologies Inc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact